Patent · US Active

PSMA-targeting imaging agents

US10918741B2 · kind B2 · utility

1Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2017
Grant dateFeb 16, 2021
Priority date—
Expiry dateJun 26, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K51/0497
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A PSMA-specific imaging agent comprising a compound according to formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.